Teleflex completed the acquisition of Palette Life Sciences for $650m.

Teleflex, an American provider of specialty medical devices, completed the acquisition of Palette Life Sciences, a fully-integrated global life sciences company, for $650m. "The original founding vision for Palette Life Sciences was to disrupt the rectal spacing market with a new product innovation that would serve as a better option for doctors and their patients. As a result, Palette would achieve strong market growth and expansion, creating high value for patients and shareholders alike. Entering into the agreement with Teleflex serves as an important milestone in achieving our vision," Travis Gay, Palette Life Sciences Chief Commercial Officer and Co-Founder.